DRAK1, NT, Blocking Peptide (DAP Kinase-related Apoptosis-inducing Protein Kinase 1), Purified

DRAK1, NT, Blocking Peptide (DAP Kinase-related Apoptosis-inducing Protein Kinase 1), Purified
Item number Size Datasheet Manual SDS Delivery time Quantity Price
D9334P.50 50 µg - -

3 - 19 business days*

459.00€
 
Peptide corresponding to amino acids 5 to 19 of human DRAK1 (1). |Apoptosis is mediated by death... more
Product information "DRAK1, NT, Blocking Peptide (DAP Kinase-related Apoptosis-inducing Protein Kinase 1), Purified"
Peptide corresponding to amino acids 5 to 19 of human DRAK1 (1). , Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase-related apoptosis-inducing protein kinases (1). DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK1 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues (1).
Supplier: United States Biological
Supplier-Nr: D9334P

Properties

Conjugate: No
Format: Purified

Database Information

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "DRAK1, NT, Blocking Peptide (DAP Kinase-related Apoptosis-inducing Protein Kinase 1), Purified"
Write a review
or to review a product.
Viewed